| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHOPHT.1993.01090010108035 |
| P698 | PubMed publication ID | 7678730 |
| P433 | issue | 1 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 104-109 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group | |
| P478 | volume | 111 |
| Q24806062 | A randomised controlled trial investigating the effect of nutritional supplementation on visual function in normal, and age-related macular disease affected eyes: design and methodology [ISRCTN78467674] |
| Q24544001 | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 |
| Q35126780 | Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies |
| Q82698020 | Age-related macular degeneration |
| Q31048292 | Age-related macular degeneration: epidemiology and optimal treatment |
| Q34784437 | An innovative approach to the determination of safety for a dietary ingredient derived from a new source: case study using a crystalline lutein product |
| Q46058281 | Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study |
| Q44588148 | Are lutein and zeaxanthin conditionally essential nutrients for eye health? |
| Q31143690 | Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study |
| Q36093266 | Association of macular pigment optical density with risk factors for wet age-related macular degeneration in the Indian population |
| Q36988482 | Botanical compounds: effects on major eye diseases |
| Q93878441 | Cardiovascular risk factors and ARM |
| Q36625672 | Celastrol protects mouse retinas from bright light-induced degeneration through inhibition of oxidative stress and inflammation |
| Q44441405 | Changes in Blood Antioxidants and Several Lipid Peroxidation Products in Women with Age-Related Macular Degeneration |
| Q77910744 | Changes in Bruch's membrane and related structures with age |
| Q33921077 | Combination of ginsenoside Rb1 and Rd protects the retina against bright light-induced degeneration |
| Q41002492 | Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration |
| Q35118257 | Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. |
| Q33922277 | Correlations Between Macular, Skin, and Serum Carotenoids |
| Q33848201 | Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials |
| Q43476226 | Did the loss of endogenous ascorbate propel the evolution of Anthropoidea and Homo sapiens? |
| Q37083770 | Diminishing risk for age-related macular degeneration with nutrition: a current view |
| Q34213525 | Dose-dependent response of serum lutein and macular pigment optical density to supplementation with lutein esters |
| Q37395303 | Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging |
| Q61976290 | Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial |
| Q35560422 | Epidemiology of age-related maculopathy: a review |
| Q40450496 | Eriodicyol inhibits osteoclast differentiation and ovariectomy-induced bone loss in vivo. |
| Q33738263 | Evidence for decreased interaction and improved carotenoid bioavailability by sequential delivery of a supplement |
| Q33301643 | Genetic markers and biomarkers for age-related macular degeneration |
| Q34468049 | Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes |
| Q28292554 | Human ocular carotenoid-binding proteins |
| Q34650775 | Identification and metabolic transformations of carotenoids in ocular tissues of the Japanese quail Coturnix japonica |
| Q24628314 | Identification of StARD3 as a lutein-binding protein in the macula of the primate retina |
| Q36014754 | In vivo macular pigment measurements: a comparison of resonance Raman spectroscopy and heterochromatic flicker photometry |
| Q71377524 | Influence of oxygen free radicals and free radical scavengers on the growth behaviour and oxidative tissue damage of bovine retinal pigment epithelium cells in vitro |
| Q30829406 | Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up |
| Q40362063 | Kinetics of 14C distribution after tracer dose of 14C-lutein in an adult woman. |
| Q33246037 | Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]. |
| Q30693939 | Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease |
| Q36239449 | Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center |
| Q36517825 | Macular pigment optical density in the elderly: findings in a large biracial Midsouth population sample |
| Q34683188 | Macular pigment: influences on visual acuity and visibility |
| Q31025663 | Macular pigment: quantitative analysis on autofluorescence images |
| Q28240096 | Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration |
| Q37349992 | Macular zeaxanthins and lutein -- a review of dietary sources and bioavailability and some relationships with macular pigment optical density and age-related macular disease |
| Q33344748 | Measuring macular pigment in vivo |
| Q36164956 | Metabolism of lutein and zeaxanthin in rhesus monkeys: identification of (3R,6'R)- and (3R,6'S)-3'-dehydro-lutein as common metabolites and comparison to humans |
| Q38174408 | Nature and nurture- genes and environment- predict onset and progression of macular degeneration. |
| Q34634743 | Neuroprotective effects of lutein in the retina |
| Q34817164 | Nonmydriatic fluorescence-based quantitative imaging of human macular pigment distributions |
| Q93102835 | Nutrients for Prevention of Macular Degeneration and Eye-Related Diseases |
| Q34132062 | Nutrition effects on ocular diseases in the aging eye. |
| Q74616550 | Nutrition supplements and the eye |
| Q33680428 | Nutritional Interventions against Age-Related Macular Degeneration |
| Q37592954 | Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review |
| Q36083941 | Nutritional modulation of age-related macular degeneration. |
| Q60060646 | Ocular Neovascularization |
| Q34021623 | Ophthalmology update for the primary practitioner. Part II. Therapeutic management of age-related macular degeneration |
| Q37801465 | Oxidation and age-related macular degeneration: insights from molecular biology |
| Q33837754 | Oxidative damage and protection of the RPE. |
| Q36853154 | Preventative ophthalmology. Age-related macular degeneration |
| Q36825090 | Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration |
| Q33308961 | Protective effects of epigallocatechin gallate after UV irradiation in cultured human retinal pigment epithelial cells |
| Q37097697 | Proteomic and phototoxic characterization of melanolipofuscin: correlation to disease and model for its origin |
| Q52657629 | RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells. |
| Q72042892 | Racial differences in the prevalence of atrophic-appearing macular lesions between black and white patients with retinitis pigmentosa |
| Q33231516 | Resonance Raman detection of carotenoid antioxidants in living human tissue |
| Q33326556 | Resonance Raman imaging of macular pigment distributions in the human retina |
| Q30858951 | Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients |
| Q37196292 | Retinal carotenoids can attenuate formation of A2E in the retinal pigment epithelium |
| Q34543564 | Risk assessment for the carotenoids lutein and lycopene |
| Q31926371 | Risk factors for age-related macular degeneration |
| Q71108625 | Risk factors of age-related maculopathy in a population 70 years of age or older |
| Q37298565 | Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD) |
| Q36257030 | Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 |
| Q38487855 | Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS). |
| Q60598791 | Serum oxidative and antioxidant parameters in a group of Italian patients with age-related maculopathy |
| Q33633313 | Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury |
| Q35789333 | Surface plasmon resonance (SPR) studies on the interactions of carotenoids and their binding proteins |
| Q39092535 | The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration |
| Q36360812 | The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) |
| Q58722677 | The Effect of Lutein on Eye and Extra-Eye Health |
| Q64050071 | The association between cigarette smoking and ocular diseases |
| Q61976272 | The effect of nutritional supplementation on the multifocal electroretinogram in healthy eyes |
| Q45683269 | The effects of a lutein-based supplement on objective and subjective measures of retinal and visual function in eyes with age-related maculopathy -- a randomised controlled trial |
| Q43141623 | The flavonoid, eriodictyol, induces long-term protection in ARPE-19 cells through its effects on Nrf2 activation and phase 2 gene expression |
| Q36317120 | The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field. |
| Q40584747 | The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q. |
| Q35028928 | The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration. |
| Q73191249 | The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration |
| Q24802193 | The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence |
| Q33677016 | The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization |
| Q33733227 | The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders |
| Q43006737 | Total parenteral nutrition, vitamin E, and reversible macular dysfunction morphologically mimicking age related macular degeneration |
| Q55919696 | Tubulins in the primate retina: evidence that xanthophylls may be endogenous ligands for the paclitaxel-binding site††This work was presented in part at the Association for Research in Vision and Ophthalmology annual meetings May 1999 and May 200 |
| Q35522994 | Upregulation of CCR3 by age-related stresses promotes choroidal endothelial cell migration via VEGF-dependent and -independent signaling |
| Q46871532 | Use of a 13C tracer to investigate lutein as a ligand for plasma transthyretin in humans |
| Q36929380 | Vascular endothelial growth factor in eye disease |
| Q44023449 | Vitamins and trace elements in age-related macular degeneration. Current recommendations, based on the results of the AREDS study |
Search more.